Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial-Reference-Cited by-同舟云学术

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial

Published:2016-02 Issue:10021 Volume:387 Page:866-873
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Forbes John F,Sestak Ivana,Howell Anthony,Bonanni Bernardo,Bundred Nigel,Levy Christelle,von Minckwitz Gunter,Eiermann Wolfgang,Neven Patrick,Stierer Michael,Holcombe Chris,Coleman Robert E,Jones Louise,Ellis Ian,Cuzick Jack

Publisher

Elsevier BV

Subject

General Medicine

Reference26 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Heterogeneity of ductal carcinoma in situ and its effects on management;Mokbel;Lancet Oncol,2006

3. Addressing overtreatment of screen detected DCIS: the LORIS trial;Francis;Eur J Cancer,2015

4. Trends in treatment patterns and outcomes for ductal carcinoma in situ;Worni;J Natl Cancer Inst,2015

5. Post-operative radiotherapy for ductal carcinoma in situ of the breast;Goodwin;Cochrane Database Syst Rev,2013

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on the management of ductal carcinoma in situ of the breast: current approach and future perspectives;Japanese Journal of Clinical Oncology;2024-09-02

2. Systematic assessment of HER2 status in ductal carcinoma in situ of the breast: a perspective on the potential clinical relevance;Breast Cancer Research;2024-08-27

3. Biogenic nanoparticles: pioneering a new era in breast cancer therapeutics—a comprehensive review;Discover Nano;2024-08-03

4. Ductal Carcinoma In Situ;Hematology/Oncology Clinics of North America;2024-08

5. Consenso mexicano de cáncer mamario. Manejo del cáncer de mama temprano;Gaceta Mexicana de Oncolog�a;2024-06-25